The other two proteins, protein Shisa 3 homolog (PS-3) and platelet-activating factor acetylhydrolase (PAF-AH), may be related to high CAD burden in low-risk subjects (Ferrannini et al., 2021). This evidence concerns the gene TAS2R6P and coronary artery disorder.